[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"trial:NCT07024992":3,"trial-entities:NCT07024992":141,"trial-summary:NCT07024992":145},{"id":4,"nct_id":4,"org_study_id":5,"brief_title":6,"official_title":7,"overall_status":8,"completion_date":9,"status_verified_date":10,"last_update_date":11,"start_date":12,"sponsor_name":13,"lead_sponsor_class":14,"has_dmc":15,"brief_summary":16,"detailed_description":17,"conditions":18,"keywords":22,"study_type":31,"primary_purpose":32,"phases":33,"enrollment_info":35,"interventions":38,"primary_outcomes":55,"secondary_outcomes":74,"sex":78,"minimum_age":79,"maximum_age":80,"healthy_volunteers":81,"eligibility_criteria":82,"std_ages":103,"locations":106,"central_contacts":125,"overall_officials":134,"references":139,"see_also_links":140},"NCT07024992","STUDY00004985","Enhancing Smoking Cessation for African American People Everywhere","A National Test of a Culturally Tailored Smartphone-based Smoking Cessation and Mental Health Intervention for Black Adults With HIV","RECRUITING","2029-06-30","2026-07","2026-07-13","2026-06-30","University of Houston","OTHER",true,"The present study aims to investigate the efficacy of an mHealth smoking cessation and HIV disease management intervention among a nationally representative sample of African America\u002FBlack (hereafter refer to as Black) persons with HIV\u002FAIDS (PWH) who smoke cigarettes. Participants will be randomized into one of three conditions: (1) the intervention, ESCAPE (Enhancing Smoking Cessation for African American People Everywhere) + Nicotine Replacement Medications (NRT), (2) the National Cancer Institute's (NCI) quitSTART app, the standard mobile smoking cessation treatment + NRT, and (3) an assessment-only control group + NRT.","This nationwide trial aims to evaluate the efficacy of a smartphone-based smoking cessation and HIV care management intervention culturally tailored for Black PWH who smoke cigarettes with treated and untreated HIV.A RCT will be conducted with 300 Black PWH who smoke cigarettes to evaluate the efficacy of the intervention. Participants will be randomly assigned to the smartphone-based ESCAPE intervention + NRT, the National Cancer Institute's smartphone-based quitSTART intervention + NRT, or assessment-only control + NRT. Participants will complete a self-screener, baseline appointment, 8 weeks of ecological momentary assessments (EMAs), 8 weekly follow-up assessments, 10 monthly check-in surveys, a 28-week follow-up, and a final 54-week follow-up. A subset of participants will also be selected to complete a qualitative interview at the end of their 6th week in the study.",[19,20,21],"ESCAPE Intervention+NRT","quitSTART Intervention+NRT","CTRL+NRT",[23,24,25,26,27,28,29,30],"HIV","Anxiety Sensitivity","Mobile Health","Smoking","Smoking Cessation","African American","Ecological Momentary Assessments","Just-in-Time Adaptive Intervention","INTERVENTIONAL","TREATMENT",[34],"PHASE2",{"count":36,"type":37},300,"ESTIMATED",[39,45,50],{"type":40,"name":41,"description":42,"armGroupLabels":43},"BEHAVIORAL","ESCAPE app + NRT","ESCAPE is a mobile intervention that targets anxiety sensitivity among Black adults who smoke cigarettes and have HIV. This intervention is framed within the cultural context of interoceptive stress among Black adults who smoke, which is supported by theory, empirical evidence, and characteristics of this group. The intervention employs a variety of features to educate users on how to deal with stress, anxiety, and nicotine withdrawal symptoms. The app contains a series of on-demand features, including a coping toolkit, stress management trainings, and a series of educational videos. ESCAPE also utilizes Ecological Momentary Assessments (EMAs) to gather information and provide personalized messages to users in real time. All participants will receive free nicotine replacement therapy (NRT).",[44],"ESCAPE intervention + NRT",{"type":40,"name":46,"description":47,"armGroupLabels":48},"quiSTART app + NRT","quitSTART is a smartphone-based National Cancer Institute (NCI) intervention for standard mobile smoking cessation treatment. The intervention contains features that allow its' users to better understand their smoking patterns, and build skills needed to become and stay smoke free. The app allows users to track cravings and delivers motivational messages to users for each craving they track. All participants will receive free nicotine replacement therapy (NRT).",[49],"quitSTART intervention + NRT",{"type":40,"name":51,"description":52,"armGroupLabels":53},"Control (CTRL)","The CTRL group will complete the same baseline survey, follow-up surveys, and ecological momentary assessments schedule as the ESCAPE app + NRT and the quitSTART app + NRT group. All participants will receive free nicotine replacement therapy (NRT). They will not receive additional intervention content.",[54],"Control (CTRL) + NRT",[56,60,64,67,71],{"measure":57,"description":58,"timeFrame":59},"7-day Biochemically Verified Point Prevalence Abstinence (PPA)","PPA will be defined as no cigarette smoking within the past 7 days, and will be biochemically verified via assessment of expired carbon monoxide (\\\u003C 6 ppm).","Baseline appointment through the 54-week follow-up, inclusive of follow-up assessments (Weeks 1-6, 28, and 54-week).",{"measure":61,"description":62,"timeFrame":63},"Anxiety","Anxiety will be evaluated via Overall Anxiety Severity Index Scale (OASIS).","Baseline appointment through the 54-week follow-up, inclusive of follow-up assessments (Weeks 1-6, 28, and 54-week)",{"measure":65,"description":66,"timeFrame":59},"Depression","Depression will be evaluated via the Overall Depression Severity Index Scale (ODSIS).",{"measure":68,"description":69,"timeFrame":70},"HIV (and general) Quality of Life","HIV (and general) quality of life will be evaluated using the the World Health Organization HIV Quality of Life Brief Scale and the EuroQol 5-Dimension 5-Level (EQ-5D-5L).","Baseline appointment through the 54-week follow-up, inclusive of every assessment containing these survey items (weeks 1-6, 28, and 54-week follow-ups)",{"measure":72,"description":73,"timeFrame":70},"HIV Care Adherence\u002FEngagement","HIV-related outcomes will be evaluated using the dichotomous variables (e.g., ART medication non-adherence and missed treatment appointments).",[75],{"measure":76,"description":77,"timeFrame":63},"Anxiety Sensitivity Reduction","Anxiety sensitivity will be evaluated using the Short Scale Anxiety Sensitivity Index (SSASI).","ALL","18 Years",null,false,{"inclusion":83,"exclusion":96,"raw_text":102},[84,85,86,87,88,89,90,91,92,93,94,95],"At least 18 years of age","Identify as Black\u002FAfrican American","Living with HIV","Biochemical verification of self-reported smoking status following minimum study specified smoking rate endorsement","Motivated to quit smoking","Must be ready to quit cigarettes within 14 days of full enrollment","Moderate or higher anxiety sensitivity OR elevated anxiety OR depression","Must be willing to download a mobile app onto their personal phone","Must be willing to use NRT","Possess an Android\u002FApple smartphone that is compatible with the mobile app","Demonstrate 7th grade level proficiency in English (≥4 on the Rapid Estimate of Adult Literacy in Medicine-Short Form \\[REALM-SF\\])","Valid proof of identification (photo of valid US ID)",[97,98,99,100,101],"Legal situations which may interfere with study participation","Not being fluent in English","High blood pressure that is not under control","Having experienced a heart attack within the past 2 weeks","Pregnant of planning to become pregnant within the next six months","Inclusion Criteria:\n\n* At least 18 years of age\n* Identify as Black\u002FAfrican American\n* Living with HIV\n* Biochemical verification of self-reported smoking status following minimum study specified smoking rate endorsement\n* Motivated to quit smoking\n* Must be ready to quit cigarettes within 14 days of full enrollment\n* Moderate or higher anxiety sensitivity OR elevated anxiety OR depression\n* Must be willing to download a mobile app onto their personal phone\n* Must be willing to use NRT\n* Possess an Android\u002FApple smartphone that is compatible with the mobile app\n* Demonstrate 7th grade level proficiency in English (≥4 on the Rapid Estimate of Adult Literacy in Medicine-Short Form \\[REALM-SF\\])\n* Valid proof of identification (photo of valid US ID)\n\nExclusion Criteria:\n\n* Legal situations which may interfere with study participation\n* Not being fluent in English\n* High blood pressure that is not under control\n* Having experienced a heart attack within the past 2 weeks\n* Pregnant of planning to become pregnant within the next six months",[104,105],"ADULT","OLDER_ADULT",[107],{"facility":108,"status":8,"city":109,"state":110,"zip":111,"country":112,"contacts":113,"geoPoint":122},"University of Oklahoma Health Sciences Center","Oklahoma City","Oklahoma","73104","United States",[114,119],{"name":115,"role":116,"phone":117,"email":118},"Michael Businelle, Ph.D.","CONTACT","405-271-8001","Michael-Businelle@ouhsc.edu",{"name":120,"role":116,"phone":117,"email":121},"Krista Kezbers, Ph.D.","krista-kezbers@ouhsc.edu",{"lat":123,"lon":124},35.46756,-97.51643,[126,130],{"name":127,"role":116,"phone":128,"email":129},"Lorra Garey, Ph.D.","713-743-8056","llgarey@central.uh.edu",{"name":131,"role":116,"phone":132,"email":133},"Katie Pereira, M.S.","713-743-9567","kmpereira@central.uh.edu",[135],{"name":136,"affiliation":137,"role":138},"Michael S. Businelle, Ph.D.","University of Oklahoma Health Sciences","PRINCIPAL_INVESTIGATOR",[],[],{"nct_id":4,"conditions":142,"biomarkers":144},[143,26],"HIV Infection",[],{"nct_id":4,"found":15,"summary":146,"prompt_version":156},{"design":147,"status":148,"heading":149,"summary":150,"follow_up":151,"word_count":152,"commitments":153,"compensation":154,"drugs_mentioned":155},"This study is a randomized controlled trial, meaning participants will be randomly assigned to one of three groups. It plans to include 300 participants.","completed","Smoking Cessation for African Americans with HIV","This study is looking at ways to help African American people living with HIV quit smoking. It's testing two smartphone apps, ESCAPE and quitSTART, both used with nicotine replacement therapy (NRT), against a control group also receiving NRT. The ESCAPE app is designed specifically for Black adults who smoke and have HIV, focusing on anxiety related to smoking. The quitSTART app helps users understand their smoking habits and build skills to quit. Researchers want to see if these apps help people quit smoking for good, and how they affect anxiety and depression. You might be able to join if you are at least 18, identify as Black\u002FAfrican American, live with HIV, smoke cigarettes, are motivated to quit within 14 days, and have moderate to high anxiety or depression. The study plans to enroll 300 participants, but its current recruitment status is unclear.","Participants will be followed for 54 weeks after their baseline appointment to assess smoking abstinence, anxiety, and depression.",142,"You would complete a self-screener, a baseline appointment, 8 weeks of daily assessments, 8 weekly follow-up assessments, 10 monthly check-in surveys, and two longer follow-up appointments at 28 and 54 weeks.","Not stated in the trial record.",[],"v2"]